Global Tissue Engineering Market - 2023-2030

Global Tissue Engineering Market - 2023-2030

Global Tissue Engineering Market size is valued at USD 1.2 billion in 2022, it is expected to reach USD 1.7 billion by 2030, with growth at a CAGR of 4.8% over the forecast period 2023-2030. The trend such as the shift towards 3D bioprinting technology due to its precise potential to create intricate tissue structures according to patient-specific tissues and organs is expected to dominate the global tissue engineering market.

The global tissue engineering market has grown significantly in recent years and is projected to continue on its upward trend. The market is undergoing a transformational period, influenced by several significant trends such as remarkable potential shown by stem cell therapy, organ-on-chip technology, and gene editing and CRISPR technology.

Furthermore, the rising prevalence of neurological disorder, cardiovascular and orthopedic disorders, technological advancements such 3D bioprinting and stem cell therapies, increasing aging population, growing demand for bone implants due to the increasing road accident and trauma related injury cases are driving up the tissue engineering market size.

The growing research activities for treating disease using tissue engineering approach and presence of establish biopharmaceutical and pharmaceutical companies are some of the factors in demand from North American regions with significant competitors like Zimmer Biomet, Stryker Corporation, CollPlant Biotechnologies Ltd., and others actively operating in the market.

Market Dynamics

The Increasing Demand for Organ Transplant to Drive the Growth of the Tissue Engineering Market

The increasing need for organ transplants is propelling the tissue engineering market. The shortage of organ donors is escalating and has become a significant issue in the healthcare sector. For instance, according to Health Resources and Services Administration 2023 statistics around 104,234 individuals are on the national transplant waiting list. Every day, over 17 individuals die while waiting for organ transplants. Furthermore, every 10 minutes, it is reported that an organ transplant is required. In addition, as these numbers rise, it is becoming increasingly difficult to supply organs due to a scarcity of organ donors..

Tissue engineering can thus play a significant part in addressing the scarcity of organ donors by assisting in the engineering of human tissue that will replace damaged tissues and organs. Tissue engineers develop functional tissues that integrate easily into the body by combining biomaterials, cells, and bioactive chemicals. Skin, blood vessels, bladders, hearts, and other types of these tissues have already been tissue engineered and employed in the therapy of human disease. As a result of all of the above, the market is expected to grow during the forecast period.

Growing Technological Advancements and Collaborations will Drive the Tissue Engineering Market Growth

The growing technological advancement in tissue engineering techniques by collarating with different field market leaders is expected to drive the demand for the market. For instance, according to ISS National Laboratory 2023 article, the collaboration between the Wake Forest Institute for Regenerative Medicine and the RegenMed Development Organization, it aims to use the microgravity conditions of the International Space Station (ISS) National Laboratory to launch bioengineered liver and kidney constructions into space via Axiom Space's Ax-2 mission. The Researchers want to transform organ transplantation and disease modeling by studying how microgravity alters the vascularization of these tissues.

Because, unlike traditional tissue engineering, microgravity conditions enable scaffold-free tissue development, potentially simplifying and improving the entire process. Thus, success in this project could significantly reduce organ transplant waitlists, advance disease modeling for therapy testing, and provide resources for innovative cell therapies, revealing how developing potential collaborations and advancements can drive transformative progress in the tissue engineering field.

Rising Prevalence of Chronic Disease will Drive the Tissue Engineering Market Growth

The growing prevalence of chronic disease across the globe is expected to drive the demand for effective tissue engineering techniques. For instance, according to World Health Organization report of 2022, chronic disease is a combination of genetic, physiological, environmental and behavioural factors. Every year approximately 41 Billion people die due to these disease that accounts 74% of total deaths globally. Patients suffering from cardiovascular disease accounts highest number of 17.9 billion deaths every year followed by cancer.

Furthermore, as the prevalence of cancer is rising, there is need of effective technology such as 3D bioprinting to combact with growing cancer cells. For instance, an article published by EurekAlert organization in 2023, Korea Institute of Machinery and Materials (KIMM) has developed the world’s first 3D bioprinting technology that will enhance the functioning of NK immune cells. This New technology expected to improve effectiveness of cancer treatment. Thus, owing to the above factors the market is expected to drive over the forecast period,

High Cost Associated with the Tissue Engineering Technique Will Hamper the Growth of the Market

The high cost associated with the tissue engineering technique is a critical limitation for this market due to several factors, such as the initial investment for the laboratory or facility, recurrent fees, and the cost of the transplant itself. In the tissue engineering strategy, for example, the laboratory costs $50,700. In comparison, the facility investment cost for the procured-tissue procedure was US$168,750. Manufacturing costs for tissue-engineered structures can also be costly.

Additionally, the shortage of cell and tissue donation programs may contribute to tissue engineering's high cost. The demand for private and government funding, excessive healthcare spending, and the high expense of treating diabetic foot ulcers using a tissue engineering strategy may all contribute to the high cost of tissue engineering. As a result of the issues mentioned above, the tissue engineering market is expected to experience significant restraints over the forecast period.

Segment Analysis

The global tissue engineering market is segmented based on material type, application, end user and region.

Owing to the Growing Prevalence of Bone Disorders, the Orthopedics Segment Accounted for Approximately 43.2% of the Tissue Engineering Market Share

The orthopedics segment is poised to dominate the tissue engineering market due to growing focus on applying tissue engineering techniques to address orthopedic challenges. This segment is expected to grow owing to the factors such as rising prevalence bone and joint injuries, degenerative conditions, and musculoskeletal disorders, increasing aging population, and growing technological advancements.

For instance, according to the World Health Organization 2022 report, approximately 1.71 billion people are suffering from musculoskeletal conditions globally. This has led to leading causes of disability worldwide, among which low back pain has been the major cause of disability in more than 160 countries. Tissue engineering plays an important role by offering innovative solutions to repair and regenerate damaged bone and cartilage tissues.

Moreover, many companies are utilizing technological advancements such as 3D bioprinting using tissue engineering. For instance, Curiteva, the creator of the world's first 3D printed interbody spinal implants, has granted the medical device a restricted commercial distribution. For spine surgery, the Huntsville-based technology and manufacturing company uses 3D-printed spinal implants. Curiteva's recently FDA-approved Inspire platform is used to create the implants Thus, owing to the above factors the segment is expected to dominate over the forecast period.

Geographical Penetration

North America Accounted for Approximately 37.5% of the Market Share in 2022, Owing to the Rising Prevalence of Geriatric Population

North America, particularly the U.S., dominates the global tissue engineering market due to presence of huge number of key players settled in the region, technological advancements, and high research activities along with developments of 3D bioprinting, organ-on-chip, and stem cell technologies by major players in the area.

The demand for tissue engineering in the pharmaceutical industry is driven by an increase in the number of technologies and rising number of geriatric populations in the region. For instance, according to United States Census Bureau statistics, in U.S. 1 in 6 people are aging over 65. Moreover, in 2020 older population reached about 55.8 Billion or 16.8% of U.S. total population. Thus, tissue engineering will aid in restoring and improving the function of degenerated tissues, catering to the needs.

Moreover, the R&D process in this region is well established that creates opportunities for researcher to discover different technologies. For instance, in June 2023, Emulate, a company that creates in vitro drug research models, has introduced a new device dubbed Chip-A1. Chip-A1 is an extension of the company's Organ-on-a-Chip technology, which allows researchers to model human organs in vitro more accurately. The new chip improves in vitro modeling capabilities for cancer and cosmetics research, which require more precise models of human organs. The Chip-A1 technology is expected to find applications in cancer, cosmetics, and respiratory areas. Thus, owing to above factors the region is expected to grow over the forecast period.

Competitive Landscape

The major global players in the tissue engineering market include Zimmer Biomet, Stryker Corporation, 3D BioFibR Inc., Integra LifeSciences Corporation, CollPlant Biotechnologies Ltd., AbbVie (Allergan Aesthetics), Becton, Dickinson and Company, Athersys, Inc., BioTissue., Japan Tissue Engineering Co., Ltd, and among others.

COVID-19 Impact Analysis

The COVID-19 pandemic began in December 2019 with the SARS-CoV-2 virus in Wuhan, China, quickly spreading throughout the world, creating a significant impact on the tissue engineering market. The virus spreads easily by droplets from infected people, resulting in many illnesses. COVID-19 can cause major organ damage by affecting many organs. Tissue engineering approaches can be used to fix this, in which experts create novel ways to heal injured organs.

However, due to COVID-19, it has been difficult to obtain the materials needed for the present research. Shipping issues caused delays and cancellations of essential supplies, making it difficult for researchers and businesses to continue their work. Because of the pandemic, this condition hampered scientific development and had a significant impact on tissue engineering.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict has had a negative impact on the tissue engineering sector. The conflict has hampered the chances of global economic recovery, which has hampered the expansion of the tissue engineering sector. The conflict has also produced economic disruption, which has reduced demand for tissue engineering products. Thus, the conflict will create a major impact on the tissue engineering market over some period.

By Material Type
• Synthetic Materials
Polymers
Hydrogels
Ceramics
Composites
• Biologically Derived Materials
Extracellular Matrix (ECM) Proteins
Fibrin
Collagen
Silk
• Others

By Application
• Orthopedics
• Musculoskeletal & Spine
• Neurology
• Cardiology
• Skin & Integumentary
• Others

By End-User
• Hospitals
• Academic and Research Institutes
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Key Developments
• On June 13, 2023, the Indian Drugs Controller has approved the first indigenously developed tissue engineering scaffold from mammalian organs by Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), an animal-derived Class D Biomedical Device that can rapidly heal skin wounds at low cost with minimal scarring.
• On January 16, 2023, 3DBioFibR, a leading tissue engineering pioneer, announced the release of two new collagen fibre solutions, CollaFibR and CollaFibR 3D scaffold. These off-the-shelf solutions, created using 3D BioFibR's exclusive and revolutionary dry-spinning technology to generate collagen fibres at commercial scales, offer considerable advantages for tissue engineering and tissue culture applications and are now for sale.
• On January 16, 2023, BioMed X, an independent German biomedical research institute, announced that its ongoing research collaboration with AbbVie has been extended. This marks the opening of the first BioMed X Institute in the United States, which will be in New Haven, Connecticut. The new US-based research cooperation will focus on immunology and tissue engineering, following a first cooperative research study on Alzheimer's disease at the BioMed X Institute in Heidelberg, Germany.

DMI Opinion

The global tissue engineering market is expected to grow more rapidly as a result of the shift toward 3D bioprinting technology for accurate tissue structure development, with trends such as stem cell therapy, organ-on-chip technology, and gene editing driving this expansion. Rising neurological, cardiovascular, and orthopedic illnesses, as well as technical advancements such as 3D bioprinting and stem cell therapies, an aging population, and an increased need for implants due to trauma cases, all contribute to the market's growth.

North America is seeing demand, led by big players, while the necessity for organ transplantation fuels growth. However, large expenses, an absence of contributors, and geopolitical tensions pose difficulties. The orthopedics market is thriving due to bone problems, but COVID-19 and geopolitical issues are hampering progress. Finally, the tissue engineering market is characterized by new trends and opportunities.

Why Purchase the Report?
• To visualize the global tissue engineering market segmentation based on material type, application, end user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of tissue engineering market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in excel consisting of key products of all the major players.

The global tissue engineering market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies